Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 6 of 6 entries
View as:

A Phase 2, Double-blind Study to Evaluate Intranasal Trivalent Influenza Virus Vaccine in Healthy Adult

Phase: N/A Priority: Normal
NCT ID: NCT03784885 Org: User:
Start: 09/01/17 End: 10/30/18 Due: 10/30/19

Study of the Safety, Tolerability and Immunogenicity of an Intranasal Influenza Vaccine Administered to Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03293732 Org: User:
Start: 11/28/12 End: 09/30/13 Due: 09/30/14

Evaluating Safety, Tolerability, and Potential Efficacy of Intranasal AD17002 in Adults With Mild to Moderate COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05069610 Org: User:
Start: 03/21/22 End: 12/18/23 Due: 12/18/24

Tolerability and Potential Efficacy of LTh(αΚ) in Subjects With Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT04088721 Org: User:
Start: 03/26/19 End: 12/11/20 Due: 12/11/21

AD17002 Treating Poorly Controlled, Moderate to Severe Eosinophilic Asthma

Phase: N/A Priority: Normal
NCT ID: NCT05985694 Org: User:
Start: 11/27/23 End: 09/27/24 Due: 09/27/25

Evaluating the Safety and Efficacy of AD17002 Intranasal Spray in Treating Participants With Mild to Moderate COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05541510 Org: User:
Start: 12/01/22 End: 03/31/25 Due: 03/31/26